santé – Relocalisation, ARS, stocks : quelles avancées depuis la covid-19 ?

This written question asks about progress made in health policy since the COVID-19 pandemic, specifically concerning the relocation of health industries, regional health agencies (ARS), and strategic stock management. It seeks to understand advancements and challenges in ensuring national health security and supply chain resilience, potentially affecting public health services and the pharmaceutical sector.